2iQ

Galaxy Digital’s Founder and CEO Mike Novogratz bought $9.86M of $GLXY stock after the shares fell more than 40% in a month. Novogratz purchased 760,000 Class A shares at an average of $12.979 on Nov 5, just above the 52-week low of $11.78. He said there is a big gap between the share price and the value of the business, pointing to onchain finance and AI demand as long-term shifts. Galaxy has also bought back 9.8 million shares, and its Helios campus in Texas has 800 MW under long-term contracts.

TFI International's Chairman, President and CEO Alain Bédard bought CAD $2.67M of $TFII stock on Nov 2, including 20,000 shares at CAD $132, and Directors Steven Mayer, John Pratt and Debra Kelly-Ennis added about CAD $705,500 more, all within days of a 17% post-earnings drop. Combined: approximately CAD $3.37M. @tfiintl Q3 adjusted EPS rose nearly 40% to $1.67, Truckload operating income nearly doubled to $100M, and TFI posted a sub-90 operating ratio for the second consecutive quarter. The shares fell 17% because EPS missed the $1.75 consensus and US LTL remains weak.

Aberdeen Group's Chair Designate and two Directors bought £241,630 worth of $ABDN stock after Q3 sell-off. - Torbjörn Magnusson (Chair Designate): 90,190 shares worth £200,197 on Oct 30. - Arno Kitts (NE Director): 10,000 shares worth £22,038 on Oct 27. - Katie Bickerstaffe (NE Director): 9,033 shares worth £19,395 on Oct 23. Q3 AUMA of £578.9bn, interactive investor inflows up 32%, and full-year profit targets reaffirmed. Adviser outflows of £0.7bn remain the drag. @Aberdeen_plc

Stewart Information Services' CEO, Chairman and three Directors all bought stock after Q3 earnings sent the shares to a 52-week low. Combined: $460,970. Frederick Eppinger, CEO, bought 3,000 $STC shares at $44.45, worth $133,350. Chairman Thomas Apel and Directors Clifford Bradley Jr. and William Corey Jr. each added roughly $94,000 on Oct 23, and Director Deborah Matz opened a new position worth $43,910. @StewartTitleCo's Q3 adjusted EPS of $1.33 missed estimates, and the shares fell about 17% in a week to near the 52-week low of $42.73. Insiders are buying in clusters as a show of confidence in recovery.

Telix Pharmaceuticals' Founder and CEO, Chairman and a Non-Executive Director all bought stock within days of each other after Q3 results. Combined: $751,448. Christian Behrenbruch, Founder and CEO, bought 38,750 $TLX shares at A$12.894, worth $350,783. Chairman David Gill added $29,880 on Oct 23. Director William Jellison opened a new position worth $237,327. @TelixPharma's Q3 revenue rose 19% to $245M, full-year guidance of $950M-$970M was maintained, insider buying at this time shows insider's belief that stock is underpriced.

At Gentherm, a newly appointed Director and the CEO both bought stock the day after Q3 results. Combined: $662,600. Paul Mascarenas, Director, bought 20,000 $THRM shares at a weighted average of $26.63, worth $532,600. William Presley, CEO, bought 5,000 shares at $26.00, worth $130,000. Mascarenas joined the @Gentherm board on Oct 1, the day the Modine Performance Technologies combination completed. Full-year product revenue guidance rose to $1.825B-$1.925B, and the company repurchased $60M of stock in October.

Positive clinical data + strong insider buying at Rapport Therapeutics $RAPP. $1.56M cluster buy signals internal confidence in RAP-219. Analysis: 2iqresearch.com/blog/1-56-mi…

Cerillion's Founder and Non-Executive Director Guy O’Connor bought £138,000 of $CER stock at £6.90/share on Oct 21. The @cerillion shares traded around £13.50 in early June, before a Sep 14 profit warning guided full-year revenue to £46M-£48M. The company blamed delayed customer orders, while major implementations, including its largest-ever Omantel contract, continue to progress. Full-year results are due at the end of November. Insider buy at this point after several years indicate that insider expects a strong recovery.

Strong conviction from the top at Applied Digital. Founders invest $6.67M following recent AI infrastructure milestones. Analysis: 2iqresearch.com/blog/founder…

KITS Eyecare's Founder and CEO Roger Hardy bought CAD $774,950 of stock nine days after preliminary Q3 revenue grew 21.6% to a record. Hardy purchased 50,000 $KITS shares at CAD $15.499 on Oct 16, worth USD $548,131. His stake now stands at 4,156,000 shares. @kitseyecare Q3 revenue passed a $250M annualised run-rate for the first time, glasses revenue grew 59.3%, and the company holds $30.6M in cash with no debt.

Power Probe's CEO bought 255,000 $PWR:LN shares across two tranches in six days while the company simultaneously launched a $1M buyback. Chairman and Director joined too. Combined insiders: £164,534. @PowerProbeinc's H1 gross margin expanded to 50.4% from 40.8%, H2 new product launch on track, and an interim dividend of 2.16 cents declared.

A Director of Sprinklr bought $850,500 of stock at a 35% one-year low. Steve Ward purchased 150,000 $CXM shares at $5.67 on Oct 13. @Sprinklr is a 2026 Gartner Magic Quadrant Leader, holds over $420M in cash with zero debt.

Hormel Foods' Chairman just bought $201,000 of stock at its lowest price in over a decade. William Newlands purchased 10,000 $HRL shares at $20.10 on Oct 5. His total holding now stands at 76,375 shares. @HormelFoods Q3 adjusted EPS beat estimates, full-year guidance raised to $1.43-$1.51, Brakebush chicken acquisition announced on Sep 29, new CEO and CFO both in place, and the quarterly dividend declared for November.

CMC Markets' Founder who has never sold a single share since the 2016 IPO just bought £1.14M more. Lord Peter Cruddas purchased 184,011 $CMCX shares across two tranches on Oct 2. David Fineberg, CEO of the investment division, also added 23,300 shares worth £139K the same day. @CMCMarkets FY2026 profit before tax grew 20% to £101.3 million, FY2027 guidance raised, and CMC Funded, a new prop trading platform, launched on the same day as these purchases.

Xenon Pharmaceuticals' CEO and CFO bought $1.681M combined twelve days after the stock crashed 29% on a voluntary psychiatry trial pause. Ian Mortimer, CEO, purchased 30,000 $XENE shares at $37.38, worth $1,121,400. Thomas Kelly, CFO, bought 15,000 shares at $37.316, worth $559,740. @XenonPharma insiders had sold millions worth of stock over the prior 12 months with zero buying. Until now. The epilepsy NDA was filed with the FDA on Sep 17, the same day as the pause. The epilepsy programme remains fully unaffected.

A Director at Oracle, Steve Rusckowski, invested $3.484M and purchased 25,000 $ORCL shares at $139.352 on Sep 29, five days after the company revealed a $664 billion revenue backlog. @Oracle Q1 FY2027 total revenue grew 30% to $19.3 billion, with cloud infrastructure surging 121% year-over-year to $7.4 billion. Stock is down 10% year-to-date despite the growth, weighed by the force majeure notice on its New Mexico data centre.

Blue Moon Metals' CEO and Independent Chairman bought stock as five critical metals projects advance across the US and Norway. Combined: CAD $162,006. Christian Kargl-Simard, CEO, purchased 21,200 $MOON shares at CAD $6.80 on Sep 28, worth CAD $144,160. Maryse Belanger, Chairman, added 2,400 shares at CAD $7.436 on Sep 21, worth CAD $17,846. At @BlueMoonMetals a US$150-175M Springer Tungsten investment was announced on Sep 14, initial drill results confirmed 7.00 metres of 1.28% WO₃ on Sep 22, and Nussir copper is targeting production in Q3 2027.

TruFin $TRU CEO just bought £416,540 in shares after H1 results showed revenue growth and positive adjusted EBITDA. Strong confidence signal. Full story: 2iqresearch.com/blog/ceo-mak…

South Bow Corp's COO bought stock three consecutive days. Chairman joined him the day before. Combined: $512,022. Richard Prior, COO, invested $442,850 across 13,000 $SOBO shares from Sep 24-28. Hal Kvisle, Chairman, added 2,000 shares at CAD $48.75 on Sep 23, worth $69,172. @SouthBowCorp secured 20-year binding transportation commitments from its open season, Prairie Connector FID is targeted for mid-2027, and the Keystone Pipeline ran at 95% System Operating Factor in Q1 delivering approximately 616,000 barrels per day.

Selkirk Copper's CEO and two Directors bought stock two days after a PEA delivered an after-tax NPV of C$494M and 48% IRR. Combined: CAD $399,560. Colin Joudrie, CEO, invested CAD $346,000 for 250,000 $SCMI.NE shares on Sep 25. Directors Ryan Weymark and Robert McLeod added CAD $53,560 combined the day prior. @SelkirkCopper Phase 2 drilling is advancing ahead of schedule, measured and indicated copper resources increased 182% in the 2026 resource estimate, and first production from the Minto project is targeted for mid-2028.